Identification of a series of potent telomerase inhibitors using a time-resolved fluorescence-based assay
- 1 February 1998
- journal article
- research article
- Published by Wiley in Drug Development Research
- Vol. 43 (2) , 109-116
- https://doi.org/10.1002/(sici)1098-2299(199802)43:2<109::aid-ddr4>3.0.co;2-o
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Refining the telomere-telomerase hypothesis of aging and cancerNature Biotechnology, 1996
- High capacity screening of pooled compounds: Identification of the active compound without re-assay of pool membersDrug Development Research, 1996
- Telomeres, Telomerase and CancerScientific American, 1996
- Covalent modification of the interleukin‐5 receptor by isothiazolones leads to inhibition of the binding of interleukin‐5European Journal of Biochemistry, 1994
- Europium-Labeled Oligonucleotide Hybridization Probes: Preparation and PropertiesBioconjugate Chemistry, 1994
- Telomerase activity in human ovarian carcinoma.Proceedings of the National Academy of Sciences, 1994
- Telomere length predicts replicative capacity of human fibroblasts.Proceedings of the National Academy of Sciences, 1992
- Detection of amplified HTLV-I/-II viral sequences using time-resolved fluorometryAnalytical Biochemistry, 1992
- Chemical reactivity of some isothiazolone biocidesJournal of Applied Bacteriology, 1990
- Europium as a label in time-resolved immunofluorometric assaysAnalytical Biochemistry, 1984